Access Bio, Inc. (950130.KQ)

6,510.00 +100.00 (+1.56%) At close: 03:30PM KST

Access Bio, Inc.

65 Clyde Road
Suite A
Somerset, NJ 08873
United States
732 873 4040
https://accessbio.net

Sector(s): 
Industry: 
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Young-Ho Choi	CEO & President	1.59B	N/A	1964
Bo-Kyung Choi	Managing Director	986.29M	N/A	N/A
Young-Seok Hong	Managing Director	653.9M	N/A	N/A
Mr. John Kim	Managing Partner	N/A	N/A	N/A
Mr. Philip Kim CPA	Treasurer and Member of the Advisory Board	N/A	N/A	N/A
Ms. Janet Strong Ph.D.	DOD/Government Issues Advisor and Member of the Advisory Board	N/A	N/A	N/A
Mr. Andrew J. Gorman	Business Advisor and Member of the Advisory Board	N/A	N/A	N/A
N. A. Shaikh M.D., Ph.D.	Clinical Advisor and Member of the Advisory Board	N/A	N/A	N/A

Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in KRW.

Description

Access Bio, Inc. engages in the research, development, and manufacture of in vitro rapid diagnostic tests, biosensors, and molecular diagnostic products worldwide. The company provides Covid-19 detection kits, which are tests for assessing the current or past presence of SARS-CoV-2.; rapid diagnostic tests, suitable for preliminary diagnosis or emergency medical screening in medical facilities with limited resources; analyzers, designed to measure different chemicals and other characteristics in biological samples; and molecular diagnostic solutions used in analyzing biological markers in the genome and proteome. It offers its products under CareStart, CareUS, CareSURE, and CareGENE brand names. The company was incorporated in 2002 and is headquartered in Somerset, New Jersey.

Corporate governance

Access Bio, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.